In patients with type 2 diabetes
with high CV risk
with high CV risk
CV DEATH
HAS A
NEW OPPONENT
Jardiance® (Empagliflozin) is the only type 2 diabetes pill proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease
Jardiance reduce cardio-renal risk in T2D patients
Document ID: PC-KW-100542
20/12/2022
Author: Boehringer Ingelheim
Jardiance Helped slow the decline in Kidney function for T2D patients
123,000
Views
100k 340
Related content
PC-KW-100542
Production date: Dec 2022
Production date: Dec 2022